Skip to main content
SpringerLink
Log in

Hypolipidemic agent probucol (mechanisms of action, hypolipidemic effects, and clinical studies). Review

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. J. W. Barnhart, J. A. Sefranka, and D. D. McIntosh,Am. J. Clin. Nutr.,23, 1229–1233 (1970).

    Google Scholar 

  2. S. Parthasarathy, S. G. Young, J. L. Witztum, et al.,J. Clin. Invest.,77, 641–644 (1986).

    Google Scholar 

  3. V. N. Bobyrev et al.,Terap. Arkh., No. 3, 122–125 (1989).

    Google Scholar 

  4. T. A. Devyatkina,Dokl. Akad Nauk SSSR,242(2), 449–451 (1978).

    Google Scholar 

  5. V. Z. Lankin,Kardiologiya, No. 8, 42–48 (1980).

    Google Scholar 

  6. C. J. Schwartz,Am. J. Cardiol,62, 1B-5B (1988).

    Google Scholar 

  7. V. A. Barsel', I. M. Korochkin, G. V. Arkhipova, et al.,Izv. Akad. Nauk SSSR, Ser. Biol., No. 1, 75–85 (1988).

    Google Scholar 

  8. V. Z. Lankin and A. M. Vikhert,Arkh. Patol.,51(1), 80–84 (1989).

    Google Scholar 

  9. A. Szczeklic, R. J. Gryglewski, B. Domagala, et al.,Tromb. Haemost.,54, 425–430 (1985).

    Google Scholar 

  10. I. Nishigaki, M. Hagihara, H. Tsunekawa, et al.,Biochem. Med.,25, 373–378 (1981).

    Google Scholar 

  11. W. A. Harland, J. D. Gilbert, and C. J. W. Brooks,Biochim. Biophys. Acta,316, 378–385 (1973).

    Google Scholar 

  12. US Pat. No. 3576883.

  13. US Pat. No. 4719237.

  14. Jap. Pat. Nos. 80-17.316; 80-09.041.

  15. Spain Pat. No. 542659.

  16. Spain Pat. No. 549013.

  17. D. B. Jones, H. C. R. Simpson, P. Slaughter, et al.,Atherosclerosis,53, 1–7 (1984).

    Google Scholar 

  18. V. Z. Lankin, V. P. Lupanov, A. A. Lyakishev, et al.,Kardiologiya, No. 6, 87–90 (1991).

    Google Scholar 

  19. P. Zimetbaum,J. Clin. Pharmacol.,30, 3–9 (1990).

    Google Scholar 

  20. Y. Matsusawa, S. H. Yamachita, T. Funahashi, et al.,Am. J. Cardiol.,62, 67B-73B (1988).

    Google Scholar 

  21. G. Franceschini et al.,Arteriosclerosis,9, 462–469 (1989).

    Google Scholar 

  22. S. Maeda, M. Okuno, A. Abe, et al.,Atherosclerosis,79, 267–269 (1989).

    Google Scholar 

  23. E. Helve and M. J. Tikkanen,Atherosclerosis,72, 189–197 (1988).

    Google Scholar 

  24. M. J. Mellies, P. S. Gartside, L. Glatfetter, et al.,Metabolism,29, 956–964 (1980).

    Google Scholar 

  25. Y. Hsiang et al.,J. Surg. Res,50(3), 252–258 (1991).

    Google Scholar 

  26. J. T. Gwynne,Am. J. Cardiol.,62, 48B-51B (1988).

    Google Scholar 

  27. R. F. Atmeh, J. M. Stewart, D. E. Boag, et al.,J. Lipid Res.,24, 588–595 (1983).

    Google Scholar 

  28. P. Avogaro, G. B. Bon, G. Cazzolato, et al.,Arteriosclerosis,8, 79–87 (1988).

    Google Scholar 

  29. Y. A. Kesaniemi and S. M. Grundy,J. Lipid. Res.,25, 780–790 (1984).

    Google Scholar 

  30. T. A. Miettinen,Atherosclerosis,15, 163 (1973).

    Google Scholar 

  31. M. M. T. Buckley,Drugs,37, 761–800 (1989).

    Google Scholar 

  32. V. M. Revenko, V. P. Lupanov, V. Z. Lankin, et al.,Kardiologiya, No. 10, 41–44 (1991).

    Google Scholar 

  33. V. A. Dudaev, V. V. Gorin, M. V. Shingirei, et al.,Kardiologiya, No. 6, 76–78 (1984).

    Google Scholar 

  34. F. N. Marshall,Artery,10, 7–21 (1982).

    Google Scholar 

  35. A. A. Polachek, H. M. Katz, J. Sack, et al.,Curr. Med. Res. Opin.,1, 323–330 (1970).

    Google Scholar 

  36. R. Fellin, A. Gasparotto, G. Valerio, et al.,Atherosclerosis,59, 47–56 (1986).

    Google Scholar 

  37. H. L. Taylor, R. B. Nolan, R. E. Tedeschi, et al.,Clin. Pharmacol,23, 131–137 (1978).

    Google Scholar 

  38. L. I. Lokshina, G. V. Tananova, V. N. Maiorov, et al.,Sov. Med., No. 5, 67–69 (1986).

    Google Scholar 

  39. A. Berg, I. Frey, M. Baumstark, et al.,Atherosclerosis,72, 49–54 (1988).

    Google Scholar 

  40. J. Davignon,Am. J. Cardiol.,57, 22H-28H (1986).

    Google Scholar 

  41. M. Eto, T. Sato, K. Watanabe, et al.,Atherosclerosis,84, 49–53 (1990).

    Google Scholar 

  42. J. P. Paez Moreno et al.,Curr. Med. Res. Opin.,11, 523–532 (1989).

    Google Scholar 

  43. C. A. Dujovne, P. Krehbiel, and S. B. Chernoff,Am. J. Cardiol.,57, 36H (1986).

    Google Scholar 

  44. H. Minacami, Antioxidant activity of probucol,Arzneim. -Forch.,39, 1090–1091 (1989).

    Google Scholar 

  45. D. Steinberg,Am. J. Cardiol.,57, 16H-21H (1986).

    Google Scholar 

  46. W. F. Riesen, M. Keller, and R. Mordasini,Atherosclerosis,36, 201–207 (1980).

    Google Scholar 

  47. C. Cortese, C. B. Marenah, N. E. Miller, et al.,Atherosclerosis,44, 319–325 (1982).

    Google Scholar 

  48. P. J. Nestel and T. Billington,Atherosclerosis,38, 203–209 (1981).

    Google Scholar 

  49. D. McCaughan,Artery,10, 56–70 (1982).

    Google Scholar 

  50. A. Kiryakov, Yu. Kavrykova, and Z. Tinterova,Medicinal Correction of Dislipidemia in Elderly People [in Russian], Kiev (1990), pp. 36–43.

  51. C. R. Sirtori, M. Sirtori, L. Calabresi, et al.,Am. J. Cardiol.,62, 73B-76B (1988).

    Google Scholar 

  52. T. A. Miettinen, J. K. Huttunen, V. Naukkarinen, et al.,Am. J. Cardiol.,57, 49H-54H (1986).

    Google Scholar 

  53. D. A. Pietro, S. Alexander, G. Mantell, et al.Am. J. Cardiol.,63, 682–686 (1989).

    Google Scholar 

  54. S. Baker, B. I. Joffe, D. Mendelsohn, et al.,S. Afr. Med. J.,62, 7–11 (1982).

    Google Scholar 

  55. Y. Nagai, T. Nacamura, M. Kubo, et al.,Jpn. Circ. J.,53, 902 (1989).

    Google Scholar 

  56. P. Sanjurjo,Acta Paediatr. Scand.,77, 132–135 (1988).

    Google Scholar 

  57. A. Yamomoto, Y. Matsuzawa, S. Yokoyama, et al.,Am. J. Cardiol.,57, 29H-35H (1986).

    Google Scholar 

  58. A. Yamomoto, H. Hara, and S. Takaichi,Am. J. Cardiol.,62, 31B-36B (1988).

    Google Scholar 

  59. G. Walldius, L. A. Carlson, U. Erikson, et al.,Am. J. Cardiol.,62, 37B-43B (1988).

    Google Scholar 

  60. A. M. Gotto,Am. J. Cardiol.,71, 3B-8B (1993).

    Google Scholar 

  61. P. T. Kuo, A. S. Wilson, J. B. Kostis, et al.,Am. J. Cardiol.,57, 43H-48H (1986).

    Google Scholar 

  62. D. Sommariva, D. Bonfiglioli, M. Tirrito,Interh. J. Clin. Pharmacol. Ther. Toxicol,24, 505–510 (1986).

    Google Scholar 

  63. C. B. Blum and R. I. Levy, Current therapy for hypercholesterolaemia,J. Am. Med. Ass.,261, 3581–3587 (1989).

    Google Scholar 

  64. C. A. Dujovne, P. Krehbiel, S. De Coursey, et al.,Ann. Int. Med.,100, 447–482 (1984).

    Google Scholar 

  65. G. Walldius, U. Erikson, A. G. Olsson, et al.,Am. J. Cardiol.,74, 875–883 (1994).

    Google Scholar 

  66. R. W. Wissler and D. Vesselinovitch,Appl. Pathol.,1, 89–96 (1983).

    Google Scholar 

  67. Am. J. Cardiol,66, 22B–30B (1990).

  68. Am. J. Cardiol.,62, 35J–43J (1988).

  69. M. J. Tikkanen, S. Helve, and E. A. Nikkila,Eur. Heart. J.,8, 97–101 (1987).

    Google Scholar 

  70. J. L. Witztum,Circulation,79, 16–28 (1989).

    Google Scholar 

  71. J. Davignon, A. C. Nestruck, P. Alaupovic, et al.,Lipoprotein Deficiency Syndromes, A. Angel, J. Frohlich (eds.), Plenum Press, New York (1986), pp. 111–125.

    Google Scholar 

  72. T. Hirato and J. C. Mamo, “Treatment of hyperlipidemia with probucol reduces proteinuria and suppresses the development of glomerulosclerosis in aminonucleoside nephrosis,” in:Abstrs. of the IX Int. Symp. Atheroscl., Abstr. 90, Rosemont (1991).

  73. H. Iida, K. Izumino, M. Asaka, et al.,Nephron,47, 280–283 (1987).

    Google Scholar 

  74. A. L. Drash, W. A. Rudert, S. Borquaye, et al.,Am. J. Cardiol.,62, 27B-30B (1988).

    Google Scholar 

  75. Y. J. Lee, H. Daida, and H. Yokoi, “Does lipid lowering therapy prevent early restenosis after coronary angioplasty?,” in:Abstrs. of the IX Int. Symp. Atheroscl., Abstr. 184, Rosemont (1991).

  76. D. McCaughan,Probucol and the QT interval. Lancet,2, 161 (1982).

    Google Scholar 

  77. G. Troendle, J. Gueriguian, S. Sobel, et al.,Lancet,1, 1179 (1982).

    Google Scholar 

  78. L. Romics, Z. L. Littman, Z. Laszlo, et al.,Intern. J. Cardiol.,19, 303–308 (1988).

    Google Scholar 

  79. T. E. Strandberg,Gen. Pharmacol.,19, 317–320 (1988).

    Google Scholar 

  80. V. P. Lupanov, A. A. Lyakishev, M. G. Tvorogova, et al.,Kardiologiya, No. 4, 19–22 (1993).

    Google Scholar 

  81. A. S. Nechaev, G. I. Gerasimenko, N. A. Gratsianskii, et al.,Kardiologiya, No. 7, 77–90 (1993).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. A. L. Myasnikov Institute of Cardiology, Cardiologic Research Center, Russian Academy of Medical Sciences, Moscow, Russia

    A. A. Lyakishev

  2. All-Russia Research Center for Safety of Biologically Active Compounds, Kupavna, Moscow region, Russia

    V. P. Lupanov & L. D. Smirnov

Authors
  1. A. A. Lyakishev
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. P. Lupanov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. D. Smirnov
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lyakishev, A.A., Lupanov, V.P. & Smirnov, L.D. Hypolipidemic agent probucol (mechanisms of action, hypolipidemic effects, and clinical studies). Review. Pharm Chem J 29, 661–667 (1995). https://doi.org/10.1007/BF02219520

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02219520

Keywords

Search

Navigation